Astrana Health (NASDAQ:ASTH) Price Target Raised to $48.00

Astrana Health (NASDAQ:ASTH) had its target price hoisted by Stifel Nicolaus from $45.00 to $48.00 in a research report released on Thursday, Benzinga reports. They currently have a buy rating on the stock.

A number of other equities research analysts have also recently issued reports on the company. Truist Financial raised their target price on Astrana Health from $41.00 to $44.00 and gave the company a hold rating in a research note on Friday, March 1st. Baird R W upgraded Astrana Health to a strong-buy rating in a research note on Thursday, May 30th. Finally, Robert W. Baird assumed coverage on Astrana Health in a research note on Thursday, May 30th. They issued an outperform rating and a $54.00 target price on the stock. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of Buy and an average target price of $49.00.

Astrana Health Price Performance

Astrana Health stock opened at $40.56 on Thursday. The firm has a market capitalization of $2.27 billion, a P/E ratio of 30.73, a PEG ratio of 1.45 and a beta of 1.12. The stock has a fifty day simple moving average of $39.48. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 0.56. Astrana Health has a 12 month low of $28.86 and a 12 month high of $45.71.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Tuesday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). The company had revenue of $404.36 million during the quarter, compared to the consensus estimate of $413.84 million. Astrana Health had a net margin of 4.29% and a return on equity of 10.22%. The business’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.42 earnings per share. Equities research analysts anticipate that Astrana Health will post 1.41 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.